共 55 条
TNF-α-induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma
被引:44
作者:
Vroman, Heleen
[1
]
Bergen, Ingrid M.
[1
]
van Hulst, Jennifer A. C.
[1
]
van Nimwegen, Menno
[1
]
van Uden, Denise
[1
]
Schuijs, Martijn J.
[2
,3
]
Pillai, Saravanan Y.
[1
]
van Loo, Geert
[2
,4
]
Hammad, Hamida
[2
,3
]
Lambrecht, Bart N.
[1
,2
,3
]
Hendriks, Rudi W.
[1
]
Kool, Mirjam
[1
]
机构:
[1] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands
[2] VIB, Inflammat Res Ctr, Ghent, Belgium
[3] Univ Ghent, Dept Resp Med, Ghent, Belgium
[4] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium
关键词:
Asthma;
T(H)2 cells;
T(H)17 cells;
dendritic cells;
neutrophils;
CD4(+) T-CELLS;
NF-KAPPA-B;
DUST MITE ALLERGEN;
AIRWAY INFLAMMATION;
IN-VIVO;
INHALED ANTIGEN;
TH2;
RESPONSES;
OX40;
LIGAND;
CROSS-TALK;
EXPRESSION;
D O I:
10.1016/j.jaci.2017.08.012
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
Background: It is currently unknown why allergen exposure or environmental triggers in patients with mild-to-moderate asthma result in T(H)2-mediated eosinophilic inflammation, whereas patients with severe asthma often present with T(H)17-mediated neutrophilic inflammation. The activation state of dendritic cells (DCs) is crucial for both T(H)2 and T(H)17 cell differentiation and is mediated through nuclear factor kappa B activation. Ablation of TNF-alpha-induced protein 3 (TNFAIP3), one of the crucial negative regulators of nuclear factor kappa B activation in myeloid cells and DCs, was shown to control DC activation. Objective: In this study we investigated the precise role of TNFAIP3 in myeloid cells for the development of T(H)2- and T(H)17-cell mediated asthma. Methods: We exposed mice with conditional deletion of the Tnfaip3 gene in either myeloid cells (by using the lysozyme M [LysM] promotor) or specifically in DCs (by using the Cd11c promotor) to acute and chronic house dust mite (HDM)-driven asthma models. Results: We demonstrated that reduced Tnfaip3 gene expression in DCs in either Tnfaip3(CD11c) or Tnfaip3(LysM) mice dose-dependently controlled development of T(H)17-mediated neutrophilic severe asthma in both acute and chronic HDM-driven models, whereas wild-type mice had a purely T(H)2-mediated eosinophilic inflammation. TNFAIP3-deficient DCs induced HDM-specific T(H)17 cell differentiation through increased expression of the T(H)17-instructing cytokines IL-1 beta, IL-6, and IL-23, whereas HDM-specific T(H)2 cell differentiation was hampered by increased IL-12 and IL-6 production. Conclusions: These data show that the extent of TNFAIP3 expression in DCs controls T(H)2/T(H)17 cell differentiation. This implies that reducing DC activation could be a new pharmacologic intervention to treat patients with severe asthma who present with T(H)17-mediated neutrophilic inflammation.
引用
收藏
页码:1620 / 1633
页数:14
相关论文